Coapt, Chicago, announced that its COMPLETE CONTROL myoelectric system for people with upper-limb loss has received Class II medical device clearance from the U.S. Food and Drug Administration (FDA). The company said this is the only myoelectric pattern recognition system to be cleared for marketing in the United States by the FDA.
O&P Foundation Accepting Applications for Grant Program
The Orthotics and Prosthetics Foundation for Education and Research is accepting applications for its new microgrant program. The deadline to...
Read more